BBIO - CIK 0001743881
BridgeBio Pharma, Inc. has filed 777 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (386 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-06-25 | 2024-06-21 |
| Insider trade | 4 | 2024-06-25 | 2024-06-21 |
| Insider trade | 4 | 2024-06-25 | 2024-06-21 |
| Major company event | 8-K | 2024-06-24 | 2024-06-21 |
| Major company event | 8-K | 2024-06-06 | 2024-06-04 |
| Insider trade | 4 | 2024-06-05 | 2024-06-03 |
| Insider sale notice | 144 | 2024-06-03 | - |
| Insider trade | 4 | 2024-05-17 | 2024-05-16 |
| Insider trade | 4 | 2024-05-17 | 2024-05-16 |
| Quarterly report | 10-Q | 2024-05-02 | 2024-03-31 |
| Major company event | 8-K | 2024-05-02 | 2024-05-02 |
| Annual report to shareholders | ARS | 2024-04-25 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-25 | - |
| Proxy statement | DEF 14A | 2024-04-25 | 2024-06-21 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| Major company event | 8-K | 2024-03-06 | 2024-03-05 |
| Prospectus supplement | 424B5 | 2024-03-06 | - |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Prospectus supplement | 424B5 | 2024-03-04 | - |
| Major company event | 8-K | 2024-03-04 | 2024-03-01 |
| Annual report | 10-K | 2024-02-22 | 2023-12-31 |
| Major company event | 8-K | 2024-02-22 | 2024-02-22 |
| Insider trade | 4 | 2024-02-21 | 2024-02-16 |
| Insider trade | 4 | 2024-02-21 | 2024-02-16 |
| Insider trade | 4 | 2024-02-21 | 2024-02-16 |
| Insider trade | 4 | 2024-02-20 | 2024-02-15 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-16 | - |
| Insider sale notice | 144 | 2024-02-15 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Annual insider summary | 5 | 2024-02-13 | 2023-12-31 |
| Insider trade | 4 | 2024-02-13 | 2021-12-28 |
| Passive ownership stake (update) | SC 13G/A | 2024-01-29 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-23 | - |
| Major company event | 8-K | 2024-01-18 | 2024-01-17 |
| Insider trade | 4 | 2024-01-18 | 2024-01-16 |
| Insider sale notice | 144 | 2024-01-16 | - |
| Major company event | 8-K | 2024-01-08 | 2024-01-08 |
| Employee stock plan | S-8 | 2024-01-05 | - |
| Insider trade | 4 | 2023-12-28 | 2023-12-26 |
| Insider sale notice | 144 | 2023-12-26 | - |
| Insider trade | 4 | 2023-12-20 | 2023-12-18 |
| Insider trade | 4 | 2023-12-19 | 2023-12-15 |
| Insider sale notice | 144 | 2023-12-18 | - |
| Insider sale notice | 144 | 2023-12-15 | - |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider sale notice | 144 | 2023-12-01 | - |
| Activist ownership stake (update) | SC 13D/A | 2023-11-22 | - |
| Insider trade | 4 | 2023-11-20 | 2023-11-16 |
| Insider trade | 4 | 2023-11-20 | 2023-11-16 |